Literature DB >> 17140156

Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.

J Attems1, K A Jellinger.   

Abstract

OBJECTIVE: To examine the occurrence of tau pathology in the olfactory system in aged subjects and its relation to the severity of Alzheimer disease (AD) pathology.
MATERIAL AND METHODS: 273 autopsy cases (167 female, 106 male, aged 61-102, mean 83.2+/-4.5 SD years) underwent a standard neuropathological assessment with immuno-histochemical study of tau and Abeta amyloid in the olfactory bulb and nerve, and diagnosis of AD using established consensus criteria including Braak staging of neuritic AD pathology.
RESULTS: All cases of definite AD (Braak stages 5 and 6, n = 96) showed large numbers of neuropil threads and neurofibrillary tangles, with amyloid deposits in 50%, and neuritic plaques only in two cases. Braak stage 4 (n = 73) was associated with tau pathology in the olfactory system in 90.4 and amyloid deposits in 9%, Braak stage 3 (n = 56) with mainly mild to moderate olfactory tau lesions in 44.6 and Abeta deposits in 9%. Braak stage 2 (n = 22) showed olfactory tau pathology in 36.4% without amyloid deposits, whereas Braak stages 0 and 1 (n = 25) were all negative. Olfactory tau pathology showed highly significant correlation with neuritic Braak staging in the brain, while both scores showed significant but low correlation with age.
CONCLUSIONS: These data confirm previous studies demonstrating considerable tau pathology in the olfactory system in all definite AD cases, in more than 2/3 of limbic AD and in more than 1/3 of elderly individuals with or without mild cognitive impairment associated with Braak stage 2. Clinical dementia correlated with both Braak and olfactory tau scores, indicating that both are associated with a high risk of cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140156

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  53 in total

1.  Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?

Authors:  Daniel W Wesson; Donald A Wilson; Ralph A Nixon
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

2.  Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease.

Authors:  Steven E Arnold; Edward B Lee; Paul J Moberg; Lauren Stutzbach; Hala Kazi; Li-Ying Han; Virginia M Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

3.  Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment.

Authors:  Donna J Cross; Yoshimi Anzai; Eric C Petrie; Nathalie Martin; Todd L Richards; Kenneth R Maravilla; Elaine R Peskind; Satoshi Minoshima
Journal:  J Nucl Med       Date:  2013-06-26       Impact factor: 10.057

4.  Olfactory Function and Associated Clinical Correlates in Former National Football League Players.

Authors:  Michael L Alosco; Johnny Jarnagin; Yorghos Tripodis; Michael Platt; Brett Martin; Christine E Chaisson; Christine M Baugh; Nathan G Fritts; Robert C Cantu; Robert A Stern
Journal:  J Neurotrauma       Date:  2016-08-11       Impact factor: 5.269

Review 5.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

Review 6.  Olfactory dysfunction in dementia.

Authors:  Jorge Alves; Agavni Petrosyan; Rosana Magalhães
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

7.  Osmophobia and olfactory functions in patients with migraine.

Authors:  Gürkan Kayabaşoglu; Aytug Altundag; Dilcan Kotan; Denizhan Dizdar; Recep Kaymaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-30       Impact factor: 2.503

8.  MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.

Authors:  S George; E J Mufson; S Leurgans; R C Shah; C Ferrari; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2009-12-14       Impact factor: 4.673

Review 9.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

Review 10.  Neurogenesis and Alzheimer's disease: at the crossroads.

Authors:  Orly Lazarov; Robert A Marr
Journal:  Exp Neurol       Date:  2009-08-19       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.